Literature DB >> 2221058

Acute effects of insulin-like growth factor I and insulin on glucose metabolism in vivo.

R T Moxley1, P Arner, A Moss, A Skottner, M Fox, D James, J N Livingston.   

Abstract

We have compared the actions of insulin-like growth factor (IGF-I) and insulin on glucose metabolism in vivo, using the glucose clamp technique in rats. Both hormones caused dose-dependent inhibition of hepatic glucose production, stimulation of whole body glucose disposal, and an increase in the glucose metabolic rate of specific muscles. Infusion of IGF-I also decreased the plasma concentration of insulin. An an infusion rate of 0.57 nmol.kg-1.min-1, IGF-I led to stimulation of whole body glucose uptake that was similar to the glucose uptake produced by infusion of 0.01 nmol.kg-1.min-1 insulin. The glucose metabolic rate, as measured by 2-deoxy-D-glucose uptake, was comparable in quadriceps femoris, soleus, and diaphragm muscles during the infusion of 0.57 nmol.kg-1.min-1 IGF-I and 0.01 nmol.kg-1.min-1 insulin. However, at these rates of infusion, IGF-I caused only a 38 +/- 6% inhibition of hepatic glucose output compared with 66 +/- 12% inhibition by insulin (P less than 0.05). Thus, under these conditions, muscle is more responsive than liver to IGF-I, which agrees with the complement of IGF-I receptors in the two tissues.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2221058     DOI: 10.1152/ajpendo.1990.259.4.E561

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  12 in total

1.  An expression of IGF-binding proteins in normal and pre-eclamptic human umbilical cord serum and tissues.

Authors:  Edward Bańkowski; Jerzy Pałka; Stefan Jaworski
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

2.  Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.

Authors:  F M Tomas; S E Knowles; P C Owens; C S Chandler; G L Francis; F J Ballard
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

Review 3.  The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes.

Authors:  Swapnil N Rajpathak; Marc J Gunter; Judith Wylie-Rosett; Gloria Y F Ho; Robert C Kaplan; Radhika Muzumdar; Thomas E Rohan; Howard D Strickler
Journal:  Diabetes Metab Res Rev       Date:  2009-01       Impact factor: 4.876

4.  Effect of insulin-like growth factor-1 on the responses to and recognition of hypoglycemia in humans. A comparison with insulin.

Authors:  D Kerr; W V Tamborlane; F Rife; R S Sherwin
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

5.  A Novel Mutation in Insulin-Like Growth Factor 1 Receptor (c.641-2A>G) Is Associated with Impaired Growth, Hypoglycemia, and Modified Immune Phenotypes.

Authors:  Melanie R Shapiro; Timothy P Foster; Daniel J Perry; Ron G Rosenfeld; Andrew Dauber; James A McNichols; Andrew Muir; Vivian Hwa; Todd M Brusko; Laura M Jacobsen
Journal:  Horm Res Paediatr       Date:  2020-10-28       Impact factor: 2.852

6.  Effects of recombinant human insulin-like growth factor I and insulin on counterregulation during acute plasma glucose decrements in normal and type 2 (non-insulin-dependent) diabetic subjects.

Authors:  R Laager; U Keller
Journal:  Diabetologia       Date:  1993-10       Impact factor: 10.122

7.  Metabolic response of sheep skin to a chronic infusion of a variant of insulin-like growth factor I.

Authors:  J E Hocking Edwards; S K Khalaf; B R Sinclaire; J Lee; C G Prosser; P M Harris
Journal:  Biochem J       Date:  1995-06-01       Impact factor: 3.857

8.  Insulin-like growth factor 1, glycation and bone fragility: implications for fracture resistance of bone.

Authors:  Grażyna E Sroga; Ping-Cheng Wu; Deepak Vashishth
Journal:  PLoS One       Date:  2015-01-28       Impact factor: 3.240

9.  A novel heterozygous IGF-1 receptor mutation associated with hypoglycemia.

Authors:  R Solomon-Zemler; L Basel-Vanagaite; D Steier; S Yakar; E Mel; M Phillip; L Bazak; D Bercovich; H Werner; L de Vries
Journal:  Endocr Connect       Date:  2017-06-25       Impact factor: 3.335

Review 10.  Insulin-like growth factor-1 deficiency and metabolic syndrome.

Authors:  G A Aguirre; J Rodríguez De Ita; R G de la Garza; I Castilla-Cortazar
Journal:  J Transl Med       Date:  2016-01-06       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.